FIELD: pharmaceuticals.
SUBSTANCE: invention relates to use of compounds, which are N-{3-[6-(pyrrolidin-1-yl)pyridazin-3-yl]phenyl}-2-(trifluoromethyl)benzenesulphonamide, N-{3-[6-(piperidin-1-yl)pyridazine-3-yl]phenyl}-2,4,6-trimethylbenzene sulfonamide, N-{3-[6-(piperidin-1-yl)pyridazin-3-yl]phenyl}-4-(trifluoromethyl)benzenesulphonamide, etc., specified in the patent claim, for inhibiting hepatitis B virus (HBV) infection.
EFFECT: disclosed is a hepatitis B virus (HBV) inhibitor, which is a derivative of N-{3-[6-(dialkylamino)pyridazin-3-yl]phenyl}aryl sulphonamide and derivatives of N-{4-[6-(dialkylamino)pyridazin-3-yl]phenyl}aryl sulphonamide.
1 cl, 1 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
HEPATITIS B VIRUS (HBV) INHIBITOR | 2019 |
|
RU2746423C2 |
HEPATITIS B VIRUS INHIBITOR (HBV) | 2019 |
|
RU2736975C1 |
HEPATITIS B VIRUS (HBV) INHIBITOR | 2019 |
|
RU2726456C1 |
DERIVATIVES OF PHENYL-3-AMINOMETHYLQUINOLONE-2 AS INHIBITORS OF NO-SYNTHASE, METHOD FOR THEIR PREPARING, BIOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2284325C2 |
PARTIAL AGONIST OF DOPAMIN D2/D3 RECEPTORS - 4-{2-[4-(2,3-DICHLOROPHENIL)-PIPERAZIN-1-YL]-ETHYL}-PYPERIDIN-1-CARBONIC ACID METHILAMIDE, METHODS (OPTIONS) OF ITS OBTAINMENT AND APPLICATION | 2018 |
|
RU2677268C1 |
CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
METHOD FOR PRODUCTION OF N-[2-AMINO-4-(TRIFLUOROMETHYL) PHENYL]-N-PHENYL-4-(TRIFLUOROMETHYL)-BENZENE-1,2-DIAMINE AND ITS DERIVATIVES | 2016 |
|
RU2645922C2 |
DERIVATIVES OF PYRIDAZINE-3-ONE AND MEDICINAL AGENTS COMPRISING THEREOF | 2000 |
|
RU2232755C2 |
PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
PYRIDINONE AND PYRIDAZINONE DERIVATIVES | 2012 |
|
RU2632915C2 |
Authors
Dates
2020-12-17—Published
2019-10-24—Filed